stock price

Rocket Pharmaceuticals, FDA, gene therapy, Danon disease, trial design, stock price, RP-A501

Rocket Pharma gets FDA green light for gene therapy trial, stock surges

Anika Sharma

Rocket Pharmaceuticals has achieved alignment with the FDA regarding the design of a pivotal phase 2 clinical trial for a ...

Acelyrin, clinical trial data, inflammatory diseases, failed trials, ulcerative colitis, phase 3 trial, IPO, stock price

Acelyrin’s lead drug flops in phase 3 trial, wiping out half of its market value

Anika Sharma

Acelyrin, a biotech company based in Los Angeles, has delivered a shocking blow to its investors. Despite successfully raising an ...